Melanoma overdiagnosis: What do we know and what do we do?

被引:0
|
作者
Clark, Simon [1 ,2 ]
Rosendahl, Nikita [1 ]
Rosendahl, Cliff [2 ,3 ]
机构
[1] Univ Queensland, Fac Med, Brisbane, QLD, Australia
[2] Univ Tehran Med Sci, Sch Med, Dept Dermatol, TUMS, Tehran, Iran
[3] Univ Queensland, Med Sch, Gen Practice Clin Unit, Brisbane, QLD, Australia
关键词
SKIN-LESIONS; DERMOSCOPY; DIAGNOSIS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Melanoma overdiagnosis occurs when melanomas, not destined to cause morbidity or death in a patient's lifetime, are identified and treated. Objective This study considers the causes and magnitude of melanoma overdiagnosis in Australia. We also speculate about a possible benefit of overdiagnosis in Australia; namely, a reduction in excess deaths in the geographical areas where melanoma is diagnosed most frequently. Discussion Overdiagnosis can arguably be mitigated by factors that reduce the number of lesions treated for each melanoma identified. Data from the Australian Cancer Atlas show that there is a reduction in excess deaths from melanoma in geographical areas where diagnostic rates are higher (Pearson correlation coefficient r=-0.5978, 95% CI: -0.6243 to -0.5699, P<0.0001); this being the strongest inverse correlation observed among the 20 cancer types in the Atlas. Is early diagnosis of actual life-threatening melanomas in these geographical regions impacting survival? Further research is planned.
引用
收藏
页码:612 / 616
页数:5
相关论文
共 50 条
  • [41] Preeclampsia: What we know and what we do not know
    Roberts, JM
    [J]. SEMINARS IN PERINATOLOGY, 2000, 24 (01) : 24 - 28
  • [42] WHAT DO WE KNOW, AND WHAT SHOULD WE KNOW?
    Flume, Patrick A.
    [J]. PEDIATRIC PULMONOLOGY, 2009, : 144 - 145
  • [43] Racial disparities and discrimination in education: What do we know, how do we know it, and what do we need to know?
    Farkas, G
    [J]. TEACHERS COLLEGE RECORD, 2003, 105 (06): : 1119 - 1146
  • [44] What do we not know?
    Eisele, H
    [J]. KNOWLEDGE ORGANIZATION, 1997, 24 (04): : 252 - 255
  • [45] 'What Do We Know'
    Spaar, LR
    [J]. SHENANDOAH, 2002, 52 (04): : 148 - 153
  • [46] Food OIT What do we know, what don't we know, and what do we need to know?
    Ciaccio, Christina E.
    Bauer, Maureen Egan
    Nowak-Wegrzyn, Anna
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (02) : 118 - 119
  • [47] Cannabis and psychosis: what do we know and what should we do?
    Colizzi, Marco
    Murray, Robin
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2018, 212 (04) : 195 - 196
  • [48] Bifurcation Disease What Do We Know, What Should We Do?
    Latib, Azeem
    Colombo, Antonio
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (03) : 218 - 226
  • [49] The risk of viral transmission in feed: What do we know, what do we do?
    Dee, Scott A.
    Niederwerder, Megan C.
    Patterson, Gil
    Cochrane, Roger
    Jones, Cassie
    Diel, Diego
    Brockhoff, Egan
    Nelson, Eric
    Spronk, Gordon
    Sundberg, Paul
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2020, 67 (06) : 2365 - 2371
  • [50] WHAT DO WE KNOW
    PIROCANAC, D
    [J]. POLLUTION ENGINEERING, 1995, 27 (01) : 7 - 7